Metabolic therapeutics therapeutics Market Research Reports
Title | published | price | |
---|---|---|---|
Mitochondrial Diseases (Metabolic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... information on the therapeutics under development for Mitochondrial Diseases, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descrip......" | 30-Apr-2021 | $2000 | |
Non-Proliferative Diabetic Retinopathy (NPDR) (Metabolic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... R) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Non-Proliferative Diabetic Retinopathy (NPDR), complete with analysis by Stage of Development, Drug Target, Mechanism of Actio......" | 30-Apr-2021 | $2000 | |
Propionic Acidemia (Metabolic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... on the therapeutics under development for Propionic Acidemia, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacolog......" | 30-Apr-2021 | $2000 | |
Amyloidosis (Metabolic Disorder) - Drugs in Development, 2021By Global Markets Direct "...... ape.
Abnormal accumulation of amyloid protein in the tissues results in a group of diseases known as amyloidosis. It may affect the shape and functioning of the organ eventually leading to organ failure. Predisposing factors are misfoldi......" | 31-Mar-2021 | $2000 | |
Diabetic Macular Edema (Metabolic Disorder) - Drugs in Development, 2021By Global Markets Direct "...... abolic Disorders) pipeline landscape.
Diabetic macular edema (DME) occurs when blood vessels in the retina of patients with diabetes begin to leak into the macula, the part of the eye responsible for detailed central vision. Common sympt......" | 31-Mar-2021 | $2500 | |
Diabetic Peripheral Neuropathy (Metabolic Disorder) - Drugs in Development, 2021By Global Markets Direct "...... ripheral Neuropathy (Metabolic Disorders) pipeline landscape.
"Diabetic neuropathy is nerve damage caused by diabetes. The type of neuropathy occurring in the arms, hands, legsand feet is known as diabetic peripheral neuropathy. Symptoms......" | 31-Mar-2021 | $2000 | |
Hypoglycemia (Metabolic Disorder) - Drugs in Development, 2021By Global Markets Direct "...... dscape.
Hypoglycemia is a condition characterized by an abnormally low level of blood sugar (glucose). Symptoms of hypoglycemia include tachycardia, anxiety, shaking, and irritability, feelings of hunger, weakness, tiredness, dizziness, ......" | 31-Mar-2021 | $2000 | |
Insulin Resistance (Metabolic Disorder) - Drugs in Development, 2021By Global Markets Direct "...... ders) pipeline landscape.
Insulin resistance (IR) is a condition in which the body's cells become resistant to the effects of insulin. This occurs when insulin levels are sufficiently high over a prolonged period of time causing the body......" | 31-Mar-2021 | $2000 | |
Phenylketonuria (PKU) (Metabolic Disorder) - Drugs in Development, 2021By Global Markets Direct "...... s) pipeline landscape.
Phenylketonuria (also called PKU), is a rare inherited disorder that causes an amino acid called phenylalanine to build up in body. Symptoms include intellectual disability, psychiatric disorders, hyperactivity, sk......" | 31-Mar-2021 | $2000 | |
Worldwide Peptide Therapeutics In Metabolic Disorder Market Research Report 2021 by Type, Application, Participants and Countries, Forecast Year to 2026By PW Consulting "...... ically, the global Peptide Therapeutics In Metabolic Disorder market is divided into North America, Europe, Latin America, Asia Pacific, Middle East & Africa.
North America, Asia and Europe have significant position in the this market, big pla......" | 06-Mar-2021 | $3340 | |
|